• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国丙型肝炎供体状态对心脏移植结局的影响。

Effect of Hepatitis C donor status on heart transplantation outcomes in the United States.

机构信息

Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Clin Transplant. 2021 Apr;35(4):e14220. doi: 10.1111/ctr.14220. Epub 2021 Jan 18.

DOI:10.1111/ctr.14220
PMID:33420730
Abstract

BACKGROUND

Recent studies demonstrated safety and efficacy of heart transplantation (HT) from hepatitis C virus (HCV)-positive donors. We sought to evaluate the impact of HCV donor status on the outcomes of patients undergoing HT in the United States.

METHODS

We analyzed a retrospective cohort of adult patients from the United Network for Organ Sharing (UNOS) database who underwent isolated HT from 2015 until present. Primary outcomes were 30-day and 1-year overall mortality. Secondary outcomes included risk for graft failure and overall survival, incident stroke and need for dialysis during the available follow-up period. All end points were evaluated according to HCV status.

RESULTS

All-cause 30-day and 1-year mortality was similar between the two groups (3.4% vs 3.2%, P = .973 and 6.9% vs 7.8%, P = .769, respectively, for patients receiving heart grafts from HCV+ vs. HCV- donors). Graft failure was 12.8% (95% CI: 8%-19%) and 15.2% (95 CI: 15%-16%) in the HCV+ and HCV- groups, respectively (P = .92 and P = .68). Competing risk regression analysis for re-operation showed a non-significant trend for higher risk for re-transplantation in the HCV+ group (HR: 2.71; 95% CI: 0.83, 8.80, P = .097).

CONCLUSION

HCV donor status does not seem to negatively affect the outcomes of HT in the U.S population.

摘要

背景

最近的研究表明,来自丙型肝炎病毒(HCV)阳性供体的心脏移植(HT)是安全且有效的。我们旨在评估 HCV 供体状态对美国接受 HT 患者结局的影响。

方法

我们分析了美国器官共享联合网络(UNOS)数据库中从 2015 年至今接受单纯 HT 的成年患者的回顾性队列。主要结局是 30 天和 1 年总死亡率。次要结局包括移植物失败和总生存率、卒中发生率和在可获得的随访期间需要透析的发生率。所有终点均根据 HCV 状态进行评估。

结果

两组患者的全因 30 天和 1 年死亡率相似(分别为 3.4%比 3.2%,P = 0.973 和 6.9%比 7.8%,P = 0.769,分别为接受 HCV+供体和 HCV-供体心脏移植物的患者)。HCV+组和 HCV-组的移植物失败率分别为 12.8%(95%CI:8%-19%)和 15.2%(95%CI:15%-16%)(P = 0.92 和 P = 0.68)。HCV+组再次移植的风险较高,但竞争风险回归分析显示这一趋势无统计学意义(HR:2.71;95%CI:0.83,8.80,P = 0.097)。

结论

HCV 供体状态似乎不会对美国人群 HT 的结局产生负面影响。

相似文献

1
Effect of Hepatitis C donor status on heart transplantation outcomes in the United States.美国丙型肝炎供体状态对心脏移植结局的影响。
Clin Transplant. 2021 Apr;35(4):e14220. doi: 10.1111/ctr.14220. Epub 2021 Jan 18.
2
Outcomes of Adult Heart Transplantation Using Hepatitis C-Positive Donors.使用丙型肝炎阳性供体进行成人心脏移植的结果。
J Am Heart Assoc. 2020 Jan 21;9(2):e014495. doi: 10.1161/JAHA.119.014495. Epub 2020 Jan 8.
3
Effect of Hepatitis C Positivity on Survival in Adult Patients Undergoing Heart Transplantation (from the United Network for Organ Sharing Database).丙型肝炎阳性对接受心脏移植的成年患者生存的影响(来自器官共享联合网络数据库)
Am J Cardiol. 2016 Jul 1;118(1):132-7. doi: 10.1016/j.amjcard.2016.04.023. Epub 2016 Apr 20.
4
The outcome of liver grafts procured from hepatitis C-positive donors.来自丙型肝炎阳性供体的肝移植结果。
Transplantation. 2002 Feb 27;73(4):582-7. doi: 10.1097/00007890-200202270-00018.
5
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.丙型肝炎肝移植10年经验:500余例患者预后决定因素分析
Ann Surg. 2001 Sep;234(3):384-93; discussion 393-4. doi: 10.1097/00000658-200109000-00012.
6
Current Use of Hearts From Hepatitis C Viremic Donors.丙型肝炎病毒感染者心脏的使用现状。
Circ Heart Fail. 2018 Dec;11(12):e005276. doi: 10.1161/CIRCHEARTFAILURE.118.005276.
7
National trends and outcomes of heart-kidney transplantation using hepatitis C positive donors.利用丙型肝炎阳性供体进行心肾联合移植的国家趋势和结果。
Clin Transplant. 2022 Apr;36(4):e14581. doi: 10.1111/ctr.14581. Epub 2022 Feb 3.
8
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.丙型肝炎病毒血症供肺者肺移植中病毒传播的预防:一项开放标签、单中心、初步试验。
Lancet Respir Med. 2020 Feb;8(2):192-201. doi: 10.1016/S2213-2600(19)30268-1. Epub 2019 Oct 9.
9
Outcomes of Over 1000 Heart Transplants Using Hepatitis C-Positive Donors in the Modern Era.现代使用丙型肝炎病毒阳性供体进行的1000多例心脏移植的结果。
Ann Thorac Surg. 2023 Feb;115(2):493-500. doi: 10.1016/j.athoracsur.2022.11.002. Epub 2022 Nov 9.
10
Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.器官捐献者丙型肝炎病毒血清学阳性与心脏移植受者的生存情况
JAMA. 2006 Oct 18;296(15):1843-50. doi: 10.1001/jama.296.15.1843.

引用本文的文献

1
Heart Transplant Donor Selection Guidelines: Review and Recommendations.心脏移植供体选择指南:综述与建议
Curr Cardiol Rep. 2022 Feb;24(2):119-130. doi: 10.1007/s11886-021-01631-y. Epub 2022 Feb 18.